EUVIMEDOpdag EUVIMED
Crossref

FDA facing challenges: GAO

The Brown University Child & Adolescent Psychopharmacology Update · 2026-03 · 28 (3) · 7-8

DOI: 10.1002/cpu.31049 ↗

At a glance

Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-03-11.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Last month the Government Accountability Office (GAO) released a report highlighting problems faced by the Food and Drug Administration (FDA) due to funding and staffing and operational challenges over the past decade.

Cite

APA

(2026). FDA facing challenges: GAO. The Brown University Child & Adolescent Psychopharmacology Update, 28(3), 7-8. https://doi.org/10.1002/cpu.31049

Vancouver

FDA facing challenges: GAO. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(3):7-8. doi:10.1002/cpu.31049

BibTeX
@article{euvimed2026,
  title = {FDA facing challenges: GAO},
  journal = {The Brown University Child & Adolescent Psychopharmacology Update},
  year = {2026},
  volume = {28},
  number = {3},
  pages = {7--8},
  doi = {10.1002/cpu.31049}
}
Start for free →